The Bell Perspective

In an era of AI defense, Bank of America is betting on 2,500 in-person 'Scaminars.' A strategic look at why the future of fraud fighting is surprisingly human.

Biocytogen's new 'gold standard' accreditation isn't just about animal welfare. It's a calculated move to de-risk drug development and win global partners.

A new partnership between cliexa and OpiSafe integrates predictive AI with patented workflow tools, promising to reshape opioid stewardship from within the EMR.

Seadrill's move to replace secured debt with unsecured notes is more than a balance sheet tweak; it’s a strategic signal of renewed market confidence.

Sanofi's latest FDA nod for Tzield isn't just a new drug approval; it's a strategic shift from symptom management to disease modification in Type 1 Diabetes.

As the first Men's World Cup match kicks off on Canadian soil, the real game is about more than soccer—it's a calculated play for economic legacy.

As youth nicotine pouch use soars, Imperial Tobacco Canada calls for a crackdown on illicit sales. But is this a genuine public health plea or a masterful play to secure its market?

A new heavy-lift drone can autonomously airdrop supplies into contested zones with precision, signaling a fundamental shift in military and humanitarian aid.

Dynasty Financial Partners acquires consulting firm Optima Group, betting that a fully integrated platform of tech, capital, and strategy is the future of RIA support.

An award for customer service in payments? Basys just proved it's possible. We dissect the metrics and culture that are setting a new industry standard.

With a massive Walmart and CVS launch, Mineral Ice Extreme isn't just selling a new gel; it's executing a classic CPG playbook to challenge giants.

As global executives gather in Qingdao, the summit reveals China's new playbook: a targeted bid for high-tech MNEs to fuel its 15th Five-Year Plan.

Bee You Organics' recent award is more than a win for a small brand. It's a signal that the CPG landscape is being reshaped by waterless innovation.

A record $1.3B IPO, a minister's endorsement, and a new $75M fund. Apotex's TSX debut isn't just a corporate win; it's a national strategy in motion.

New research shows play instantly bonds families. For confectioner Kinder, it's also a savvy move to capture the lucrative family wellness market.

Komodor's new AI platform moves beyond reactive fixes, proactively preventing the structural inefficiencies that strand up to 30% of Kubernetes capacity.

A new poll shows crypto voters have doubled, but the real story is a deeper anxiety over data privacy that is creating a powerful new political force.

As businesses rush to advertise on ChatGPT, a critical question emerges: does it work? CallRail's new integration aims to answer that, giving SMBs the tools to measure ROI and compete in the new AI-driven landscape.

With veteran CEO Jim Kircher at the helm, Sigmatron enters a new era under private equity owner Transom Capital, poised for aggressive growth and operational overhaul.

A new deal to push advanced solar tech into emerging markets is more than a sales win; it's a strategic blueprint for navigating the future of global energy.